Analysis of the conformational preferences of (4R,5R)-4,5-Bis(alkylcarbamoyl)-1,3-dioxolanes

被引：0
|
作者：
Aleman, C.
Martinez de Ilarduya, A.
Giralt, E.
MuOoz-Guerra, S.
机构：
来源：
Tetrahedron | / 52卷 / 24期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] (4R,5R)-4,5-diphenylimidazolidinium-2-carboxylate methanol solvate
    Biskupska, Inga
    Gdaniec, Maria
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O3271 - O3273
  • [22] PHARMACOKINETICS, TISSUE DISTRIBUTION, AND EXCRETION OF CIS-MALONATO[(4R,5R)-4,5-BIS(AMINOMETHYL)-2-ISOPROPYL-1,3-DIOXOLANE]PLATINUM(II) IN DOGS
    CHO, YB
    KIM, KH
    KIM, DK
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (11) : 1280 - 1285
  • [23] Mammary excretion and placental transfer of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) in rats
    Cho, YB
    Kim, KH
    Kim, DK
    Miyamoto, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1996, 46 (09): : 926 - 930
  • [24] Synthesis and in vitro cytotoxicity of cis-(glycolato-O,O')-[2-substituted-(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II)
    Kim, DK
    Gam, JS
    Kim, HT
    Kim, KH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (07) : 771 - 774
  • [25] Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl- 1,3-dioxolane]platinum(II)
    Kim H.-T.
    Kim D.-K.
    Cho Y.-B.
    Kim T.-S.
    Jung I.
    Kim K.H.
    Heo D.S.
    Bang Y.-J.
    Shin S.-G.
    Kim N.K.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (2) : 109 - 116
  • [26] (4R,5S)/(4S,5R)-4,5-Bis(4-hydroxyphenyl)-2-imidazolines:: Ligands for the estrogen receptor with a novel binding mode
    Gust, R
    Keilitz, R
    Schmidt, K
    von Rauch, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (16) : 3356 - 3365
  • [27] Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II)
    Kim, HT
    Kim, DK
    Cho, YB
    Kim, TS
    Jung, I
    Kim, KH
    Heo, DS
    Bang, YJ
    Shin, SG
    Kim, NK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (02) : 109 - 116
  • [28] Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines
    von Rauch, M
    Busch, S
    Gust, R
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 466 - 474
  • [29] SYNTHESIS OF C-14-LABELED CIS-MALONATO[(4R,5R)-4,5-BIS(AMINOMETHYL)-2-ISOPROPYL-1,3-DIOXOLANE]PLATINUM(II) (SKI 2053R)
    KIM, DK
    KIM, Y
    RIM, J
    KIM, G
    GAM, J
    SONG, S
    YOO, K
    KIM, KH
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1994, 34 (02): : 157 - 164
  • [30] Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O')[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]platinum(II) in dogs
    Kim, DK
    Cho, YB
    Kim, HT
    Kim, TS
    Kim, KH
    Hong, WS
    ANTICANCER RESEARCH, 1996, 16 (3A) : 1167 - 1169
12345